• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Last 30 days trials
  • Symbicort Turbuhaler 30/60 Clinical Experience Investigation

Disease
asthma
Drug Name
Symbicort Turbuhaler
Generic Name
Symbicort
Sponsor
AstraZeneca
Drug Status
Approved Medicine
Phase
Non-Interventional Study
Start Date
Jan 13, 2010
Study Name
D589IL00001
Study Id
D589IL00001
ClinicalTrials.gov ID
NCT01232335
Recruiting Status
Closed
Protocol Status
Not Available
Report
Nov 14, 2012
  • D589IL00001.pdf (150 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013